Publisher
Deutscher Arzte-Verlag GmbH
Reference11 articles.
1. Hou K, Wu ZX, Chen XY, et al.: Microbiota in health and diseases. Signal Transduction and Targeted Therapy 2022; 7 (1): 135 MEDLINE
2. Rebersek M: Gut microbiome and its role in colorectal cancer. BMC Cancer 2021; 21 (1): 1325
3. Ivashko IN, Kolesar JM: Pembrolizumab and nivolumab: PD-1 inhibitors for advanced melanoma. Am J Health Syst Pharm 2016; 73 (4): 193–201
4. Gopalakrishnan V, Spencer CN, Nezi L, et al.: Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 2018; 359 (6371): 97–103 CrossRef
5. Lee KA, Thomas AM, Bolte LA, et al.: Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma. Nature Medicine 2022; 28 (3): 535–44